Hilo
It builds a wearable, Fitbit-style blood pressure health system designed to monitor hypertension without traditional arm cuffs.
Overview
Hilo develops a cuffless blood pressure health system positioned as a wearable alternative to traditional arm-cuff measurement. Its product is aimed at people managing hypertension and related cardiovascular risks, with a Fitbit-style form factor designed for more frequent monitoring. The company’s differentiation is its focus on replacing 145-year-old cuff technology with a continuous, consumer-friendly monitoring approach. Hilo raised a $19M Series B extension in July 2026, bringing total disclosed funding to $19M across the reported round.
Funding History
Hilo raises $19M Series B extension for Fitbit-style blood pressure health system: Can it replace 145-year-old cuff technology?
Frequently Asked Questions
- How much funding does AI Funding track for Hilo?
- AI Funding tracks $19M for Hilo across 1 funding round in this database.
- What does Hilo do?
- Hilo develops a cuffless blood pressure health system positioned as a wearable alternative to traditional arm-cuff measurement. Its product is aimed at people managing hypertension and related cardiovascular risks, with a Fitbit-style form factor designed for more frequent monitoring. The company’s differentiation is its focus on replacing 145-year-old cuff technology with a continuous, consumer-friendly monitoring approach. Hilo raised a $19M Series B extension in July 2026, bringing total disclosed funding to $19M across the reported round.
- Where is Hilo headquartered?
- Hilo is headquartered in Neuchâtel, Switzerland.
Related Insights
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
Thrive Capital has led funding rounds for OpenAI, Databricks, Perplexity, and Cursor. We analyze the firm's concentrated AI investment strategy and $25B+ portfolio.